Pharmaceutical Environmental Risk Assessment

Home→ERA Profiles → Crotamiton→

Crotamiton Environmental Risk Assessment (ERA) report

Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.

CAS Registry Number
483-63-6
Molecular formula
C13H17NO
Molecular weight
203.28 g/mol
Drug class
Topical antipruritic and scabicidelocal ectoparasiticide
Mechanism of action
The precise mechanism is not fully understood. Crotamiton has antipruritic effects and scabicidal activity, likely through local effects on mite physiology and sensory pathways.
Indications / reported uses
  • Topical treatment of scabies in adults and children where authorised
  • Temporary relief of itching associated with selected pruritic skin conditions; use on appropriate skin areas and according to product instructions

Sources: US DailyMed — Crotamiton cream/lotion · NLM MeSH — Crotamiton · FDA product information

View request basketPrefer email? info@toxwriter.com
Phase IPhase II where requiredEU / UK / other markets
Assessment scope

Environmental Risk Assessment (ERA)

ToxWriter provides project-specific support for the Crotamiton Environmental Risk Assessment (ERA) (the Crotamiton ERA report). The required pathway is determined by the medicinal product, active-substance form, route, intended market, use assumptions and available environmental evidence.

Assessment may cover

  • Product, active-substance identity, formulation, route and intended-market review.
  • Phase I environmental exposure screening and applicable trigger evaluation.
  • Phase II environmental fate and ecotoxicity assessment where required by the applicable pathway.
  • PEC/PNEC risk characterisation and PBT/vPvB considerations where relevant and supported by evidence.
  • Data-gap analysis, study strategy, assumptions and scientific reporting.
ERA regulatory framework

The EMA guideline sets out the EU framework for environmental risk assessment of human medicinal products. MHRA guidance describes UK expectations; the applicable scope depends on the product and submission context.